Home
Blog
Features
Sign Up
Try the Demo today!
Home
Market
Reports
Search
Alerts
Ticker
Company Name
Insider Name
Insider Trading Guide
About
Contact Us
Login
Reid Laurence
Insider Overview
Current Sentiment
Insider Transactions
Email this page »
Avg. Two Year Performance
No purchase track record
(14%)
Avg. Sale Return
(7%)
Compound
1 Mo
3 Mo
6 Mo
1 Yr
2 Yr
Average Purchase Return
--
--
--
--
--
Purchase Success Rate
--
--
--
--
--
Average Sale Return
(5%)
(9%)
(22%)
(57%)
(14%)
Sale Success Rate
2 of 7
2 of 7
1 of 7
0 of 7
3 of 7
Alnylam Pharmaceuticals Inc.
Drugs
» Biotechnology
SVP, Chief Business Officer:
Holdings:
19.87K
shares
Sentiment
Avg. Two Year Performance
No purchase track record
No sale track record
Last Three Months:
0
Net Amount
Buy:
0
--
Sell:
0
--
Decibel Therapeutics, Inc.
Other
» Other
See Remarks, Director:
Holdings: 0 shares
Sentiment
Avg. Two Year Performance
No purchase track record
No sale track record
Last Three Months:
0
Net Amount
Buy:
0
--
Sell:
0
--